Global Biomarkers Market Size, Analytical Overview, Growth Factors, Demand, Trends And Forecast To 2026

The Global Biomarkers Market is valued to reach USD 52.36 Billion by 2021, registering a CAGR of 13.2% over the forecast period 2020-2026. This is a latest report, covering the current COVID-19 impact on the market. This market report is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, sales, prices, revenues, gross margins, market shares, business strategies, top regions, demand, and developments.

Global rise in prevalence of various diseases and increase in number of treatment and diagnosis is likely to trigger the developments in the years to come. In addition, the market is also influenced by rise in number of CROs (contract research organizations) is contributing towards the market development. Factors driving the market growth include high prevalence of cancer, increasing diagnostic applications of biomarkers, low cost of clinical trials. And rising number of Contract Research Organizations (CROs).

Global Biomarkers Market Analysis by Key Players:

Siemens Healthcare

Roche Diagnostic Limited

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories Inc.

GE Healthcare Inc.

Epistem Ltd

Auson BioSystem Inc.

Biomarkers Market Segment Insights:

Biomarkers of exposure exhibits major growth opportunities in the years to come

Based on type, the biomarkers market can be segmented as biomarkers of exposure and diseases. Biomarkers of exposure maintains a dominant position within the segment as factors like rise in use of biomarkers for qualitative research for medical diagnosis associated with human body and external surroundings and rise in clinical trials and development of drugs.

Drug Discovery and Development held the highest share

Based on application, the market can be segmented as disease diagnosis, drug discovery, risk assessment, development of molecular diagnostic, forensic application and drug formulation. Drug discovery and development is the largest segment accounting for a high revenue share. Rise in demand for biomarkers by pharmaceuticals is more likely to propel the growth of segment.

To Know More About Biomarkers: https://dataintelo.com/report/biomarkers-market/

About DataIntelo:

DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info –

DataIntelo

Name – Alex Mathews

Email – [email protected]

Website – https://dataintelo.com

Address – 500 East E Street, Ontario, CA 91764, United States.